https://www.selleckchem.com/pr....oducts/monomethyl-au
ing and medical specialists for early diagnosis and adequate management of diabetes that all people can access and afford. It is aimed to investigate the disease processes and drug combinations in patients who received favipiravir treatment. This cross-sectional, analytical and retrospective study included all patients aged ≥18years (n=502) who were hospitalised in Samsun, Turkey, for COVID-19 and were given favipiravir from the date between 25 March 2020 and 3 June 2020. In total, 58.6% (n=294) of the patients were
Like
Comment
Share
